Best place to buy tesamorelin online: a buyer's reality check

Last updated 2026-07-24

is tesamorelin legal to buy online in the US

Yes, but only with a prescription, and only through a licensed pharmacy. Tesamorelin's only FDA-approved form is Egrifta (and its follow-on Egrifta SV), approved for HIV-associated lipodystrophy, specifically to reduce excess visceral abdominal fat ^[1]. That approval rests on pooled phase 3 data from two multicenter, double-blind, placebo-controlled trials with safety extension data ^[1]. Outside that indication, tesamorelin can still be prescribed off-label, and it can also be compounded. Compounding is legal under 21 U.S.C. 353a when a licensed pharmacy (503A) or outsourcing facility (503B) fills a valid prescription, and tesamorelin acetate appears on FDA's evaluated bulk substance lists for both pathways ^[2][3]. What is not legal, and what a lot of "online tesamorelin" storefronts quietly do, is sell it as a research chemical with no prescription requirement, often with a "not for human consumption" disclaimer that nobody actually believes. That framing exists to dodge FDA drug rules, not because the product is meant for a beaker. So the honest answer to "where's the best place to buy" is: wherever a licensed pharmacist is actually checking a prescription. That's the whole test.

what actually determines a legitimate source (not marketing claims)

Four things separate a real pharmacy from a gray-market seller: a prescription requirement, a named dispensing pharmacy, sourcing from the FDA bulk drug substance list, and a real product name (Egrifta, Egrifta SV, or a compounded tesamorelin acetate formulation with a lot number). If a site lets you check out without ever uploading or transmitting a prescription, that's disqualifying by itself. Legitimate telehealth-to-pharmacy models still require a licensed provider to write the script; the pharmacy just fills it. You should be able to name the dispensing pharmacy, see a lot number on the vial, and get a certificate of analysis on request. 503A compounders work from a patient-specific prescription; 503B outsourcing facilities can compound in larger batches under different quality rules, but both are supposed to draw from FDA's reviewed bulk substance lists ^[2][3], not from unregulated peptide vendors selling "for research use only." One useful gut check: search the seller's product against the FDA's own drug database. Egrifta and Egrifta SV show up in Drugs@FDA ^[4]. A compounded version won't, because compounded drugs aren't individually FDA-approved, but the pharmacy itself should have a state board of pharmacy license you can verify independently. A generic-looking peptide site with no named pharmacy, no prescription gate, and a PayPal checkout is not a pharmacy. It's a vendor.

egrifta vs compounded tesamorelin: what's the real difference

Egrifta is the FDA-approved brand, tested in the trials that got it approved. Compounded tesamorelin uses the same active peptide but is prepared by a pharmacy under 503A or 503B rules rather than manufactured under a New Drug Application. | Feature | Egrifta / Egrifta SV | Compounded tesamorelin |

do you need a prescription to buy tesamorelin

Yes. There is no legitimate legal pathway to buy tesamorelin in the US without a prescription. Egrifta is a prescription-only drug under its FDA approval, and compounded tesamorelin is only lawful when a pharmacy is filling a valid prescription under 21 U.S.C. 353a ^[5]. Sites that sell tesamorelin vials as a "research peptide" with no prescription step are operating outside that framework. FDA's own regulatory intent test looks at how a product is labeled and marketed, more than what a disclaimer says ^[6], and a vial sold with dosing suggestions for humans, injection supplies, and reconstitution instructions is being marketed for human use regardless of the fine print. Getting a prescription usually means a telehealth visit or an in-person consult where a provider reviews your history, confirms an appropriate reason to prescribe (on-label or off-label), and sends the script to a pharmacy. That's the extra step that gray-market sellers are selling you a way to skip. It's also the step that gets you a pharmacist checking your dose and a real product instead of a mystery vial.

what does tesamorelin actually treat, and does that match why you want it

Tesamorelin's approved indication is narrow: reduction of excess visceral abdominal fat in HIV patients with lipodystrophy ^[1][7]. It is a growth hormone-releasing hormone (GHRH) analogue that stimulates the body's own pulsatile GH release, rather than delivering GH directly ^[7]. The trial base is specific to that population. Pooled phase 3 data showed visceral fat reduction with an acceptable safety profile in HIV patients with excess abdominal fat ^[1]. Follow-up work has looked at fat quality independent of fat quantity ^[8], liver fat and NAFLD outcomes in HIV , liver enzyme improvement tied to visceral fat reduction , and even neurocognitive outcomes in people with HIV and abdominal obesity ^[9]. A 2024 study also looked at efficacy and safety in people with HIV on integrase inhibitor regimens specifically ^[3]. What that evidence does not establish is general fat loss, bodybuilding-style body recomposition, or anti-aging use in people without HIV-associated lipodystrophy. If you're buying tesamorelin for those reasons, you're using an approved drug's approval halo to justify a use case the trials never tested. That doesn't mean off-label use is automatically wrong, providers do prescribe off-label all the time, but it does mean you should not expect the same evidence quality backing it. Check tesamorelin for the fuller trial breakdown.

how much does tesamorelin cost, and why do prices vary so much online

Prices vary a lot depending on whether you're buying branded Egrifta, insurance-covered Egrifta, or compounded tesamorelin, and depending on dose and supply length. As a rough structural matter: branded drug pricing reflects manufacturing, marketing, and NDA-holder overhead; compounded pricing reflects the pharmacy's own compounding costs and markup, with no brand premium but also no brand-level manufacturing oversight. A price that looks dramatically lower than anything else you've seen, especially from a site with no named pharmacy, should raise a flag rather than feel like a win. You have no way to independently verify what's actually in an unregulated vial: concentration, sterility, or even whether it's tesamorelin at all. For actual current price ranges and what drives them, see tesamorelin cost, since specific dollar figures shift often enough that a static number here would go stale.

how is tesamorelin dosed, and does that affect where you should buy it

Standard Egrifta dosing in the approved trials was a subcutaneous injection, and population pharmacokinetic modeling has been used to characterize exposure in both HIV-infected patients and healthy subjects . Getting the dose and reconstitution right matters more with tesamorelin than with a pill, because it's a lyophilized peptide that has to be reconstituted correctly before injection. That's actually a strong argument for buying only from a source that gives you real instructions and pharmacist support, more than a vial and a hope. See tesamorelin dosage, the tesamorelin dosage calculator, and tesamorelin reconstitution before you ever draw up a syringe. A pharmacy that can't answer basic reconstitution questions isn't one you want filling this prescription.

what side effects and safety issues should you know about before buying

Tesamorelin's studied side effects include injection site reactions, joint or muscle pain (arthralgia/myalgia), peripheral edema, and effects on glucose metabolism, since it works by increasing GH and downstream IGF-1 ^[7][10]. Pooled phase 3 safety extension data found the profile acceptable for the studied population ^[1], but acceptable in a monitored trial isn't the same as risk-free. Because tesamorelin raises GH and IGF-1, it carries theoretical concerns relevant to anyone with a history of active malignancy, and glucose tolerance should be watched, particularly in anyone with pre-diabetes or diabetes risk factors. Inflammatory marker changes have also been studied in relation to visceral fat reduction . None of this is a reason to avoid an appropriately prescribed course, but it is a reason to want a real prescriber checking your labs and history first, not a website checkout page. Full detail lives at tesamorelin peptide side effects.

how do you verify a pharmacy is actually legitimate before you order

Check five things before you pay: state pharmacy board license, a named pharmacist you can actually call, a real prescription requirement, sourcing from FDA's bulk substance list, and a lot number with a certificate of analysis available. State boards of pharmacy maintain license lookups; a legitimate 503A or 503B pharmacy will be licensed in the state it operates from and often in states it ships to. If a site can't tell you which pharmacy is filling the order, or hides behind a generic "our labs" description, that's your answer already. Reputable sourcing means the pharmacy is drawing from bulk substances that FDA has evaluated for 503A or 503B use ^[2][3], not from an unlisted overseas peptide supplier. This is also where a provider-reviewed route earns its keep: Tesamorelin Co's role is connecting people to that kind of reviewed pathway rather than compounding or manufacturing anything itself, and the actual fulfillment happens through a licensed pharmacy partner, not a warehouse selling vials directly to consumers.

is compounded tesamorelin as good as the FDA-approved version

It's the same active peptide, but it is not the same regulatory product, and that distinction matters more than marketing usually admits. Egrifta went through FDA's New Drug Application process, with pooled phase 3 trial data specifically on the finished product ^[1]. Compounded tesamorelin is prepared by a pharmacy from a bulk substance that FDA has separately evaluated for compounding use ^[2][3], but the finished compounded product itself hasn't gone through the same trial and manufacturing review. In practice, that means compounded tesamorelin can be a reasonable, legal option for off-label use or for patients who can't access or afford Egrifta, provided it comes from a real 503A or 503B pharmacy. It is a worse option when it comes from an unlicensed source with no batch testing, because you lose the quality assurance that either the FDA approval pathway or a proper compounding pharmacy's own controls would otherwise give you. A recent meta-analysis of randomized controlled trials looked specifically at body composition, hepatic fat, and metabolic and safety outcomes for tesamorelin as a drug class in HIV-associated lipodystrophy ^[11], which is useful context but doesn't substitute for compounded-product-specific testing.

what should you actually do if you're considering buying tesamorelin

Start with a real conversation with a prescriber, on-label if you have HIV-associated lipodystrophy, off-label with clear eyes if you don't. Ask directly whether they're prescribing Egrifta or a compounded version, and ask which pharmacy will fill it. Before you order anything, read the actual trial evidence for the indication you're being treated for, more than the approval headline; the pooled phase 3 data ^[1] and the follow-up NAFLD and body composition work ^[8][11] are all specific to HIV-associated lipodystrophy populations. If your use case is different, know that going in. Skip any seller that has no prescription gate, no named pharmacy, and no lot number. That's not a shortcut to a better price, it's a shortcut around every safeguard that exists specifically because this is an injectable GH-axis drug, not a supplement. A provider-reviewed pathway that routes you to a licensed, named pharmacy partner is slower and sometimes pricier than a gray-market vial. It's also the version where someone with a license is actually responsible for what's in the syringe.

Frequently asked questions

Can you buy tesamorelin online legally without a prescription?

No. Tesamorelin is a prescription drug in its FDA-approved Egrifta form, and compounded versions are only legal when a licensed 503A or 503B pharmacy fills a valid prescription under 21 U.S.C. 353a. Sites selling it as a no-prescription "research chemical" are operating outside that legal framework, regardless of what the label disclaims.

What's the difference between Egrifta and generic tesamorelin?

Egrifta (and Egrifta SV) is the FDA-approved brand backed by pooled phase 3 trial data in HIV-associated lipodystrophy. There is no FDA-approved generic; "generic tesamorelin" you find online is almost always pharmacy-compounded tesamorelin acetate, made from a bulk substance on FDA's 503A/503B lists rather than through the New Drug Application process.

Is compounded tesamorelin safe?

It can be, when sourced from a licensed 503A or 503B pharmacy using bulk substances FDA has evaluated for compounding. It carries less regulatory oversight than the approved Egrifta product because the finished compounded batch itself isn't separately trial-tested. Unlicensed sellers with no lot numbers or certificates of analysis are a different, much riskier category.

How much does tesamorelin cost per month?

Cost varies widely by brand versus compounded form, dose, and insurance coverage for the approved HIV lipodystrophy indication. Rather than quote a figure likely to go stale, see the dedicated cost breakdown for current ranges and what drives the difference between branded and compounded pricing.

Does tesamorelin work for general fat loss or anti-aging?

It isn't approved for that. The FDA approval and the phase 3 trial evidence behind tesamorelin cover reduction of excess visceral abdominal fat specifically in HIV-associated lipodystrophy. Using it for general fat loss or anti-aging is off-label, and that use case hasn't been established by the same trial evidence backing the approved indication.

What side effects should I watch for with tesamorelin?

Studied effects include injection site reactions, joint and muscle pain, peripheral edema, and changes in glucose metabolism tied to increased GH and IGF-1 activity. Pooled phase 3 safety extension data found the profile acceptable in the studied HIV population, but anyone with diabetes risk or a history of malignancy should discuss this specifically with a prescriber before starting.

How do I check if an online tesamorelin seller is legitimate?

Confirm they require an actual prescription, name the specific pharmacy filling your order, can provide a lot number and certificate of analysis, and are licensed with a state board of pharmacy. A site with none of these, just a checkout page and vague sourcing language, isn't a pharmacy regardless of how professional it looks.

Can I get tesamorelin covered by insurance?

Sometimes, for the on-label HIV-associated lipodystrophy indication, since Egrifta is an FDA-approved drug for that use. Off-label prescriptions and compounded formulations are typically cash pay, since insurers generally don't cover off-label peptide use or compounded drugs the same way they do approved on-label prescriptions.

Is tesamorelin the same as HGH?

No. Tesamorelin is a GHRH analogue, meaning it stimulates your pituitary gland to release its own growth hormone in a pulsatile pattern, rather than delivering synthetic growth hormone directly. That mechanism is part of why its trial evidence and regulatory pathway differ from direct HGH products.

What is the FDA-approved use for tesamorelin?

Egrifta and Egrifta SV are FDA-approved to reduce excess visceral abdominal fat in HIV-infected patients with lipodystrophy, based on pooled phase 3 double-blind, placebo-controlled trial data with safety extension follow-up. That is the only on-label indication; any other use is off-label.

Why do tesamorelin prices vary so much between sellers?

Branded Egrifta carries manufacturing and NDA-holder costs baked into the price, while compounded tesamorelin reflects a pharmacy's own compounding and markup without that brand premium. Unlicensed sellers sometimes price far lower still, which usually reflects the absence of any real quality control rather than a genuine deal.

Do I need bloodwork before starting tesamorelin?

A responsible prescriber will typically review your history and relevant labs, including glucose metabolism markers, given tesamorelin's effect on GH and IGF-1 levels. This is exactly the kind of screening step that a no-prescription online vial seller skips entirely, which is one of the clearest signs of a gray-market source.

Sources

1. PubMed, J Clin Endocrinol Metab 2010 (PMID 20554713): Pooled analysis of two multicenter, double-blind, placebo-controlled phase 3 trials of tesamorelin in HIV patients with excess abdominal fat, including safety extension data, underlies the FDA approval for reducing visceral abdominal fat.
2. PubMed, Nature Reviews Drug Discovery 2011 (PMID 21283099): Tesamorelin is a GHRH analogue that stimulates the body's own pulsatile growth hormone release rather than delivering GH directly.
3. Cornell Law School, 21 U.S.C. 353a (pharmacy compounding): Pharmacy compounding of drugs, including tesamorelin, is legal under 21 U.S.C. 353a only when a licensed pharmacy fills a valid patient-specific prescription.
4. eCFR, 21 CFR 216.23 (503A Bulks List): Bulk drug substances eligible for use in 503A pharmacy compounding are listed under 21 CFR 216.23.
5. eCFR, 21 CFR 216.24 (503B Bulks List): Bulk drug substances eligible for use in 503B outsourcing facility compounding are listed under 21 CFR 216.24.
6. eCFR, 21 CFR 201.128 (meaning of intended uses): FDA determines a product's intended use based on labeling, marketing, and circumstances of distribution, not solely on a disclaimer.
7. FDA, Drugs@FDA database: Egrifta and Egrifta SV are listed as FDA-approved drug products in the Drugs@FDA database.
8. PubMed, J Infect Dis 2025 (PMID 39813152): Tesamorelin's effects on neurocognitive impairment have been studied specifically in persons with HIV and abdominal obesity.
9. PubMed, Ann Pharmacother 2012 (PMID 22298602): Tesamorelin, as a GHRH analogue, is associated with side effects including injection site reactions and effects related to increased GH/IGF-1 activity in HIV-associated lipodystrophy.
10. PubMed, AIDS 2021 (PMID 33756511): Tesamorelin has been shown to improve fat quality independent of changes in fat quantity.
11. PubMed, Obes Res Clin Pract 2026 (PMID 41545261): A meta-analysis of randomized controlled trials examined body composition, hepatic fat, metabolic, and safety outcomes of tesamorelin in HIV-associated lipodystrophy.
12. PubMed, Clin Pharmacokinet 2015 (PMID 25358450): A population pharmacokinetic analysis characterized tesamorelin exposure in HIV-infected patients and healthy subjects.
13. PubMed, AIDS 2017 (PMID 28832410): Visceral fat reduction with tesamorelin was associated with improved liver enzymes in people with HIV.
14. PubMed, Lancet HIV 2019 (PMID 31611038): A randomized, double-blind, multicenter trial evaluated tesamorelin's effects on non-alcoholic fatty liver disease in HIV.
15. PubMed, JCI Insight 2020 (PMID 32701508): Tesamorelin's effects on hepatic transcriptomic signatures were studied in HIV-associated NAFLD.
16. PubMed, AIDS 2011 (PMID 21516030): Tesamorelin's effects on inflammatory markers in HIV patients with excess abdominal fat were studied in relation to visceral adipose reduction.